Search results for "Estrogen"

showing 10 items of 530 documents

TFOS DEWS II Sex, Gender, and Hormones Report

2017

One of the most compelling features of dry eye disease (DED) is that it occurs more frequently in women than men. In fact, the female sex is a significant risk factor for the development of DED. This sex-related difference in DED prevalence is attributed in large part to the effects of sex steroids (e.g. androgens, estrogens), hypothalamic-pituitary hormones, glucocorticoids, insulin, insulin-like growth factor 1 and thyroid hormones, as well as to the sex chromosome complement, sex-specific autosomal factors and epigenetics (e.g. microRNAs). In addition to sex, gender also appears to be a risk factor for DED. “Gender” and “sex” are words that are often used interchangeably, but the…

Malemedicine.medical_specialtyDry eye workshopKeratoconjunctivitis SiccaDiseaseAffect (psychology)03 medical and health sciences0302 clinical medicineRisk FactorsService utilizationInternal medicineSex gendermedicineHumansSignificant riskDry eye diseaseRisk factorSex Characteristicsbusiness.industryESTRÓGENOSTFOSFemale sexGenderEstrogensHormoneHormonesDEWS II Dry eye disease Dry eye workshop Gender Hormones Sex TFOS OphthalmologyOphthalmologyEndocrinologyDEWS II030221 ophthalmology & optometryDry Eye SyndromesFemaleSexbusiness030217 neurology & neurosurgeryClinical psychologyHormone
researchProduct

Estradiol selectively stimulates endothelial prostacyclin production through estrogen receptor-α

2010

Estradiol (E2) acts on the endothelium to promote vasodilatation through the release of several compounds, including prostanoids, which are products of arachidonic acid metabolism. Among these, prostacyclin (PGI2) and thromboxane A2 (TXA2) exert opposite effects on vascular tone. The role of different estrogen receptors (ERs) in the PGI2/TXA2 balance, however, has not been fully elucidated. Our study sought to uncover whether E2 enhances basal production of PGI2 or TXA2 in cultured human umbilical vein endothelial cells (HUVECs), to analyze the enzymatic mechanisms involved, and to evaluate the different roles of both types of ERs (ERα and ERβ). HUVECs were exposed to E2, selective ERα (1,3…

Malemedicine.medical_specialtyEndotheliumDiarylpropionitrileEstrogen receptorProstacyclinBiologyThromboxane A2chemistry.chemical_compoundThromboxane A2EndocrinologyCytochrome P-450 Enzyme SystemInternal medicinemedicineEstrogen Receptor betaHumansMolecular BiologyCells CulturedEstradiolGroup IV Phospholipases A2Estrogen Receptor alphaEndothelial CellsProstanoidEpoprostenolIntramolecular OxidoreductasesEndocrinologymedicine.anatomical_structurechemistryCyclooxygenase 1cardiovascular systembiology.proteinFemalelipids (amino acids peptides and proteins)Endothelium VascularThromboxane-A synthaseEstrogen receptor alphamedicine.drugJournal of Molecular Endocrinology
researchProduct

Mitochondrial oxidant generation is involved in determining why females live longer than males

2006

Females live longer than males in many mammalian species, including humans. This natural phenomenon can be explained on the basis of the mitochondrial theory of aging. Mitochondria are a major source of free radicals in cells. Mitochondria from female rats generate half the amount of hydrogen peroxide than those of males and have higher levels of mitochondrial reduced glutathione. The latter is due to females behaving as double transgenic in over-expressing antioxidant enzymes. Estrogens bind to the estrogen receptors and subsequently activate the mitogen activated protein (MAP) kinase and nuclear factor kappa B (NFkappaB) signalling pathways, resulting in an upregulation of antioxidant enz…

Malemedicine.medical_specialtyMitochondrial DNALongevityEstrogen receptorMitochondrionBiologymedicine.disease_causechemistry.chemical_compoundDownregulation and upregulationInternal medicinemedicineAnimalsHumansSex CharacteristicsEstrogensGlutathioneOxidantsMitochondriaOxidative StressEndocrinologychemistryFemalePhytoestrogensSignal transductionOxidative stressSignal TransductionFrontiers in Bioscience
researchProduct

Formation and metabolism of catecholestrogens in depressed patients.

1990

Abstract The evidence that catecholestrogens are formed in the brain and exert behavioral effects in animal models suggests that these steroids might have psychotropic activities. In the present investigation, the formation and metabolism of catecholestrogens were studied in depressed patients. Twenty-four-hr urine samples were collected from 6 male patients (59 ± 8 years) with endogenous retarded depression (subtype primary, endogenous, and recurrent according to Research Diagnostic Criteria) and from 12 male control subjects (51 ± 4 years). The patients were treated with the monoamine oxidase inhibitor tranylcypromine (10–40 mg/day for 3–4 weeks). The concentrations of primary estrogens, …

Malemedicine.medical_specialtyMonoamine oxidase inhibitorDepressive Disordermedicine.drug_classTranylcypromineEndogenyRadioimmunoassayEstrogensMetabolismUrineBiologyMiddle AgedEstrogens CatecholExcretionEndocrinologyInternal medicinemedicineHumansTranylcypromineBiological PsychiatryDepression (differential diagnoses)medicine.drugBiological psychiatry
researchProduct

Post-weaning xenohormone intake affects adult rat submandibular gland in a sex-dependent manner

2018

International audience; OBJECTIVES: We previously reported that maternal exposure to genistein, vinclozolin, ingested alone or in combination, affects submandibular salivary glands of rats' offspring's. Here, we investigated the responsiveness of submandibular gland when such xenohormone exposure occurs later in life. MATERIALS AND METHODS: Chemicals were given orally to male and female Wistar rats (1mg/kg body weight per day), from weaning to adulthood. Submandibular glands and plasma were collected at postnatal day 100 for histological and molecular analysis. RESULTS: Whereas no effect was observed in females, increases in granular convoluted tubules area coupled with a modification of sa…

Malemedicine.medical_specialtyOffspringSubmandibular GlandPhytoestrogenssalivary glandWeaning03 medical and health scienceschemistry.chemical_compound0302 clinical medicineSex Factorsstomatognathic systemInternal medicineProgesterone receptormedicineWeaningAnimalsVinclozolinRNA MessengerCystatin CGeneral DentistryOxazolesbiologySalivary glandbusiness.industryMucinsex-dimorphismAndrogen Antagonists030206 dentistryTransforming Growth Factor alphaSubmandibular glandGenisteinRatsEndocrinologymedicine.anatomical_structureendocrine disruptorsepidermal growth factorOtorhinolaryngologyCystatin CchemistryReceptors Androgen030220 oncology & carcinogenesisbiology.proteinFemalebusiness[SDV.AEN]Life Sciences [q-bio]/Food and Nutrition[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
researchProduct

Perinatal xenohormone exposure impacts sweet preference and submandibular development in male rats.

2013

Objective To determine the effect of perinatal exposure to low doses of genistein and/or vinclozolin on submandibular salivary gland (SSG) development in juvenile and adult male rats and to establish a link with sweet preference. Material and Methods Female rats received orally (1 mg kg−1 body weight/day) genistein and vinclozolin, alone or in combination, from the first gestational day up to weaning. Sweet preference was assessed at weaning and in adulthood in male offspring; submandibular glands were then collected to study the morphogenesis and mRNA expression of steroid receptors, growth factors and taste related proteins. Results Exposure to genistein and/or vinclozolin resulted in a h…

Malemedicine.medical_specialtyOffspringsalivary glandsSubmandibular Glandendocrine disruptor mixtureGenisteinPhytoestrogensBiology03 medical and health scienceschemistry.chemical_compoundFood Preferences0302 clinical medicineFetusSaccharinstomatognathic systemInternal medicineProgesterone receptormedicineWeaningEndocrine systemAnimalsVinclozolinRats WistarGeneral DentistryOxazoles030304 developmental biology0303 health sciencesPerinatal Exposuregrowth factorAndrogen AntagonistsSex hormone receptorGenisteinRatsEndocrinologyOtorhinolaryngologychemistryAnimals NewbornTastephytoestrogen[SDV.AEN]Life Sciences [q-bio]/Food and Nutrition030217 neurology & neurosurgeryOral diseases
researchProduct

Actions of sex hormones on the brain

1992

1. The brain is a target for sex steroid hormones. As a result of sex hormone actions on the brain various behavioral changes are observed in animal and man. This paper gives a brief overview over the multiple central nervous functions that are under modulatory control of sexual hormones and describes the complex sex steroid actions on the brain by giving an example for "activating" and "organizing" effects of estrogens on noradrenergic neurons in the brain of rats. 2. Estradiol-17 beta induced sex specific alterations in the turnover of noradrenaline in the preoptic area and mediobasal hypothalamus showing "female" or "male" responses. 3. Neonatal manipulations of female rat pups by testos…

Malemedicine.medical_specialtyOvariectomyNorepinephrineNorepinephrineSex hormone-binding globulinPregnancyInternal medicinemedicineAnimalsTestosteroneGonadal Steroid HormonesBiological PsychiatryTestosteronePharmacologyNeurotransmitter AgentsEstradiolbiologyBrainEstrogensRats Inbred StrainsSex hormone receptorPreoptic AreaRatsPreoptic areaEndocrinologyAnimals NewbornSex steroidbiology.proteinFemaleOrchiectomyDefeminizationmedicine.drugHormoneProgress in Neuro-Psychopharmacology and Biological Psychiatry
researchProduct

Implications for Estrogens in Parkinson's Disease: An Epidemiological Approach

2007

Abstract: Evidence from experimental and epidemiological studies suggests a role of sex hormones in the pathogenic process leading to neurodegenerative diseases, (i.e., Alzheimer's and Parkinson's disease). The effects of sexual steroid hormones are complex and vary with the events of women's fertile life. Estrogens are supposed to influence dopamine synthesis, metabolism, and transport; however, there is no consensus regarding the direction, locus, and mechanism of the effect of estrogens on the dopaminergic system. A neuroprotective effect of estrogens has been demonstrated in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-animal models of Parkinson's disease (PD). Epidemiological st…

Malemedicine.medical_specialtyParkinson's diseaseMenopause PrematureDiseaseBioinformaticsNeuroprotectionGeneral Biochemistry Genetics and Molecular Biologychemistry.chemical_compoundHistory and Philosophy of ScienceInternal medicinemedicineAnimalsHumansSex RatioLife lengthIncidenceGeneral NeuroscienceMPTPDopaminergicEstrogensParkinson Diseasemedicine.diseaseRatsMenopauseEndocrinologychemistryFemalePsychologyHormoneAnnals of the New York Academy of Sciences
researchProduct

Improvement of the circulatory function partially accounts for the neuroprotective action of the phytoestrogen genistein in experimental ischemic str…

2012

Abstract We tested the hypothesis that the phytoestrogen genistein protects the brain against ischemic stroke by improving the circulatory function in terms of reduced production of thromboxane A2 and leukocyte–platelet aggregates, and of preserved vascular reactivity. Ischemia-reperfusion (90 min-3 days, intraluminal filament) was induced in male Wistar rats, and functional score and cerebral infarct volume were the end points examined. Genistein (10 mg/kg/day) or vehicle (β-cyclodextrin) was administered at 30 min after ischemia or sham-operation. Production of thromboxane A2 and leukocyte–platelet aggregates, as well as reactivity of carotid artery to U-46619 (thromboxane A2 analogue) an…

Malemedicine.medical_specialtyPlatelet AggregationIschemiaGenisteinPhytoestrogensNeuroprotectionBrain IschemiaThromboxane A2Thromboxane A2chemistry.chemical_compoundInternal medicinemedicineAnimalsPlateletRats WistarStrokePharmacologyChemistrymedicine.diseaseGenisteinRatsStrokeNeuroprotective AgentsEndocrinologyCirculatory systemIschemic strokeEuropean Journal of Pharmacology
researchProduct

Inhibition of Platelet Aggregation Caused by Estrogen Treatment in Patients with Carcinoma of the Prostate

1975

Platelet aggregation is increased in patients with carcinoma of the prostate treated with estrogens. Hence, these patients have a high incidence of cardiovascular and thromboembolic diseases. Platelet aggregation has been tested with the platelet aggregation test. It was inhibited by administration of 500 mg. acetylsalicylic acid twice daily. An aggregation inhibiting effect has been found in all 38 patients. To reduce the excess hazards of cardiovascular complications of estrogens in treating carcinoma of the prostate acetylsalicylic acid is recommended as an adjunct therapy.Estrogen therapy for prostatic carcinoma may lead to the development of cardiovascular complications, such as thromb…

Malemedicine.medical_specialtyPlatelet Aggregationmedicine.drug_classUrologyPopulationPharmacologyPlatelet AdhesivenessProstateInternal medicineCarcinomaHumansEndocrine systemMedicineCastrationeducationDiethylstilbestroleducation.field_of_studyAspirinEstradiolbusiness.industryGenitourinary systemProstatic NeoplasmsCancerEstrogensmedicine.diseaseEndocrinologymedicine.anatomical_structureEstrogenbusinessHormoneJournal of Urology
researchProduct